Comparison of the effect of lansoprazole and omeprazole on intragastric acidity and gastroesophageal reflux in patients with gastroesophageal reflux disease
I. Janczewska et al., Comparison of the effect of lansoprazole and omeprazole on intragastric acidity and gastroesophageal reflux in patients with gastroesophageal reflux disease, SC J GASTR, 33(12), 1998, pp. 1239-1243
Background: Lansoprazole (LAN) and omeprazole (OME) heal esophagitis effect
ively and to similar extents, but LAN has a faster effect on the relief of
symptoms of gastroesophageal reflux. However, no strict comparison of the t
wo proton pump inhibitors' effect on acid reflux and gastric acidity has be
en published. The aim of this study was to compare the effects of LAN and O
ME on gastroesophageal reflux with simultaneous measurements of gastric aci
dity in patients with established gastroesophageal reflux disease (GERD) an
d esophagitis. Methods: Fourteen patients with endoscopically verified eros
ive esophagitis and with a pretreatment esophageal 24-h pH measurement show
ing acid reflux to the esophagus participated in the study. This was a doub
le-blind, randomized study with crossover design. Before (day 0) and on the
last day (day 5) of each treatment period with encapsulated 30 mg LAN or 2
0 mg OME daily, 24-h intraesophageal and intragastric acidity were measured
with antimony electrodes connected to an ambulatory pH recording system. R
esults: Ten of 14 patients completed the study. There were no differences i
n intragastric or intraesophageal acidity or the number of reflux episodes
on day 0 between the two treatments. Both LAN and OME treatments increased
the median and nocturnal intragastric pH and decreased the 24-h area under
the time curve for intragastric acidity significantly and to about the same
extent (79% and 69% acid inhibition by LAN and OME, respectively) (NS). Ho
wever, the percentage of time with pH below 4 in the esophagus was signific
antly less during LAN treatment (1.92% +/- 2.29; mean +/- standard deviatio
n) than during OME treatment (4.76% +/- 2.88%) on day 5 (P = 0.002). There
were also significantly fewer reflux episodes >5 min during treatment with
LAN (1.00 +/- 1.33) than with OME (2.90 +/- 2.42) at the end of the treatme
nt period (P = 0.031). Conclusions: In this study lansoprazole and omeprazo
le had a comparable effect on gastric acidity in patients with established
GERD with esophagitis. However, 30 mg lansoprazole daily reduced the acidit
y in the oesophagus and the number of refluxes more effectively than 20 mg
omeprazole daily. This might indicate that proton pump inhibitors affect th
e esophageal clearance and/or influence the lower esophageal sphincter diff
erently.